GFJ ESG Acquisition I SE

  • ISIN: LU2358378979

Nachricht vom 22.10.2021 | 21:45

GFJ ESG Acquisition I SE: Disclosure of the total number of voting rights and capital, in accordance with the Law and Grand-ducal Regulation of 11 January 2008 on transparency requirements for

GFJ ESG Acquisition I SE / Total Voting Rights Announcement
22.10.2021 / 21:45
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

ANNEX B

Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the Law and Grand-ducal Regulation of 11 January 2008 on transparency requirements for issuers

1. Identity of the issuer or the underlying issuer of existing shares to which voting
rights are attachedi (including the issuer reference number allocated by the CSSF)
  GFJ ESG Acquisition I SE
2. Identity of the notifier (if another person makes the notification on behalf of the issuer)
   
3. Total number of shares composing the share capital of the notifying issuer
  18.750.000
4. Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii
  18.750.000
5. Total number of voting rights, excluding suspended voting rights (exercisable voting rights) (optional)
   
6. Origin of the changeiii
  First admission to trading of Class A shares on the regulated market (regulierter Markt) of t
   
7. Date when the change occurred 18/10/2021
8. In the previous notification (optional)
  - the total number of shares was of
  - the total number of voting rights was of
- the total number of exercisable voting rights was of
 

 

i Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

ii For further details on the total number of voting rights, please refer to point 1(b) of Circular CSSF 08/349.

iii As, for example, a capital increase or reduction.



22.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021